Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present CRYO-CELL International, Inc. (OTC: CCEL).

Full DD Report for CCEL

You must become a subscriber to view this report.


Recent News from (OTC: CCEL)

CRYO-CELL International reports Q3 results
CRYO-CELL International ( OTCPK:CCEL ): Q3 GAAP EPS of $0.03. More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: October, 15 2018 17:03
Cryo-Cell Reports Fiscal Third Quarter 2018 Results
OLDSMAR, Fla., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended...
Source: GlobeNewswire
Date: October, 15 2018 17:00
Making Bank: Global Cord Blood Corporation
Earlier this year, the China Cord Blood Corporation (NYSE: CO ), practiced in the art of subtlety, changed its name to the Global Cord Blood Corporation. The Board reasoned that the change better reflected its future development direction and business strategy. So if they weren’t alread...
Source: SeekingAlpha
Date: August, 27 2018 13:46
CRYO-CELL International reports Q2 results
CRYO-CELL International ( OTCPK:CCEL ): Q2 EPS of $0.07 More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: July, 16 2018 17:06
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2018 Financial Results
OLDSMAR, Fla., July 16, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2018.  ...
Source: GlobeNewswire
Date: July, 16 2018 17:00
Cryo-Cell: A Cheap, Predictable Business With Significant Growth Potential
Stem cells have the amazing ability to self-renew and differentiate into a variety of specialized cells. Because of these unique properties, they can be used to treat over 80 diseases and counting - including a wide range of cancers, genetic diseases, and blood disorders. Some of the least con...
Source: SeekingAlpha
Date: June, 15 2018 12:38
Cryo-Cell Consummates Acquisition of CORD:USE Assets and Extends Its Leadership Position Into the Public Cord Blood Banking Arena
OLDSMAR, Fla., June 15, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that it has completed its acquisition of  substantially all ...
Source: GlobeNewswire
Date: June, 15 2018 09:00
Cord Blood Banking Leader Cryo-Cell Acquires CORD:USE Cord Blood Bank, Inc.
OLDSMAR, Fla., June 04, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that it has entered into an agreement (the “Asset Purchase...
Source: GlobeNewswire
Date: June, 04 2018 09:00
CRYO-CELL International reports Q1 results
CRYO-CELL International ( OTCPK:CCEL ): Q1 EPS of -$0.36 More news on: CRYO-CELL International, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: April, 16 2018 17:22
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2018 Financial Results
OLDSMAR, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2018.&#x...
Source: GlobeNewswire
Date: April, 16 2018 17:14

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A7.94N/AN/A0
2018-12-13N/A7.94N/AN/A0
2018-12-127.807.948.047.803,229
2018-12-117.857.847.897.551,557
2018-12-107.607.597.607.362,625

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-121,1503,22935.6147Short
2018-12-111351,5578.6705Cover
2018-11-211,4405,12028.1250Cover
2018-11-201,2501,85067.5676Short
2018-11-192001,34314.8920Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CCEL.


About CRYO-CELL International, Inc. (OTC: CCEL)

Logo for CRYO-CELL International, Inc. (OTC: CCEL)

Based in Oldsmar, Florida, with over , clients worldwide, Cryo Cell is one of the largest and most established family cord blood banks. ISO : certified and accredited by the AABB, Cryo Cell operates in a state of the art Good Manufacturing Practice and Good Tissue Practice cGMP/cGTP compliant facility. The Menstrual Stem Cell service was introduced in November as the first and only service that empowers women to collect and cryopreserve menstrual flow containing undifferentiated adult stem cells for future utilization by the donor or possibly their first degree relatives in a manner similar to umbilical cord blood stem cells. For more information, visit www.celle.com. OTCQB Symbol: CCEL. Expectant parents or healthcare professionals may call STOR CELL or visit www.cryo cell.com.

 

Contact Information

 

 

Current Management

  • David I. Portnoy / CoCEO
  • Mark L. Portnoy / CoCEO
  • Jill M. Taymans / VP, Fin., IR
  • David I. Portnoy / Chairman
  • Anthony Atala /
  • Harold D. Berger /
  • George Gaines / Director
    • George Gaines has worked as a marketing sciences professional for over years. He completed his doctorate at the University of Georgia in and served as an Associate Professor at The University of New Orleans and Louisiana State University Medical Center until . During his academic career, Dr. Gaines authored and coauthored more than books, journal articles, and papers and training sessions presented at professional organizations. He directed numerous doctoral dissertations and masters theses. For the next years, Dr. Gaines was an officer for some of the world s most prestigious international marketing research organizations, including The Gallup Organization, TNSResearch International, and IpsosSynovate. His wellrounded private sector research included two years at The Southern Company, the largest electric holding company in the US. He also conducted research for numerous technology companies such as Picker International, Sensormatic, and Lufthansa Technik. His last years were spent as Director of Consumer Insights, Outback Steakhouse International. Dr. Gaines has lived in Princeton, NJ, Wiesbaden, Germany Phoenix, New York City, and Atlanta. He and his family currently reside in Tarpon Springs, Florida.
  • Mark L. Portnoy /
  • Jonathan H. Wheeler /

Current Share Structure

  • Market Cap: $100,909,699 - 03/16/2018
  • Authorized: 20,000,000 - 03/12/2018
  • Issue and Outstanding: 13,544,926 - 03/12/2018
  • Float: 10,000,000 - 02/28/2011

 


Recent Filings from (OTC: CCEL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 18 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 28 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: February, 15 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 17 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 17 2017

 

 


Daily Technical Chart for (OTC: CCEL)

Daily Technical Chart for (OTC: CCEL)


Stay tuned for daily updates and more on (OTC: CCEL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CCEL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CCEL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CCEL and does not buy, sell, or trade any shares of CCEL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/